Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study.

Saved in:
Bibliographic Details
Title: Treatment with tenofovir disoproxil fumarate or entecavir in chronic hepatitis B virus-infected patients with renal impairment: results from a 7-year, multicentre retrospective cohort study.
Authors: Lampertico P; Milan, Italy., Berg T; Leipzig, Germany., Buti M; Barcelona, Spain., Pathil A; Heidelberg, Germany.; Frankfurt, Germany., Petersen J; Hamburg, Germany., Ryder SD; Nottingham, UK., Zoulim F; Lyon, France., Botros I; Foster City, CA, USA., Flaherty JF; Foster City, CA, USA., Jump B; Foster City, CA, USA., Op den Brouw ML; Foster City, CA, USA., van Troostenburg A; Foster City, CA, USA., Ramroth H; Foster City, CA, USA.
Corporate Authors: ReCoRd (Retrospective, Cohort, Renal, Viread) Investigators' Group
Source: Alimentary pharmacology & therapeutics [Aliment Pharmacol Ther] 2020 Aug; Vol. 52 (3), pp. 500-512. Date of Electronic Publication: 2020 Jun 25.
Publication Type: Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 8707234 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1365-2036 (Electronic) Linking ISSN: 02692813 NLM ISO Abbreviation: Aliment Pharmacol Ther Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1365-2036
DOI:10.1111/apt.15901